Case Report: Lymphodepletion followed by CAR-T cell therapy with Idecabtagen vicleucel in a patient with severe renal impairment

Overview of attention for article published in Frontiers in oncology, November 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 8 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 18,670 followers.

Case Report: Lymphodepletion followed by CAR-T cell therapy with Idecabtagen vicleucel in a patient with severe renal impairment https://t.co/1uMApZ6RMl

30 Nov 2023

Reply Repost Favourite

RT @FrontOncology: New research: Case Report: Lymphodepletion followed by CAR-T cell therapy with Idecabtagen vicleucel in a patient with s…

14 Nov 2023

Reply Repost Favourite

New research: Case Report: Lymphodepletion followed by CAR-T cell therapy with Idecabtagen vicleucel in a patient with severe renal impairment: Acute kidney injury and chronic kidney disease is common in multiple myeloma. Fludarabine which is… https://t.co

14 Nov 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.